NANOBOTS COMMING TO A FLU SHOT CLINIC NEAR YOU SOON , page


Pages:
ATS Members have flagged this thread 2 times
Topic started on 4-12-2009 @ 09:16 AM by neverknwo
PROOF THAT YOUR FLU SHOT WILL TURN YOU INTO A CYBORG

www.youtube.com...




$9.3 million award to boost nanotech vaccine research

Michigan Nanotechnology Institute and NanoBio Corporation to work in tandem to test nanoemulsion-based vaccines against common diseases

nevernwo.blogspot.com...

ANN ARBOR, Mich. - University of Michigan efforts to develop new nanoemulsion-based vaccines for a variety of diseases will move forward much more quickly thanks to a large federal award.

The National Institute of Allergy and Infectious Diseases has awarded U-M a contract for $9,340,522 over five years. Of that total, $5,224,548 will fund research at the Michigan Nanotechnology Institute for Medicine and Biological Sciences at U-M (MNIMBS), and $4,115,974 will fund work at Ann Arbor-based NanoBio Corporation, the institute’s research partner for the project.

"This contract allows us to develop the process to apply our nanoemulsion technology to almost any form of antigen. We believe this will facilitate a number of new vaccines as well as improve existing vaccines," says James R. Baker Jr., M.D., the grant’s principal investigator, director of the Michigan Nanotechnology Institute, and Ruth Dow Doan Professor of Internal Medicine at U-M. He is also founder and CEO of NanoBio Corporation, in which he holds a financial interest.

A nanoemulsion vaccine consists of a nanoemulsion and an inactivated pathogen or protein derived from the pathogen. The nanoemulsion acts as an adjuvant, an ingredient in most vaccines that enhances the immune response to the weakened or partial pathogen.

Nanoemulsions, a technology developed and patented by U-M and licensed to NanoBio Corporation, have proved to be effective adjuvants.

In a number of previous preclinical studies at U-M, nanoemulsion-based vaccines, which are given in the nose, proved non-toxic and produced strong immunity against influenza, anthrax, smallpox, HIV and hepatitis B. NanoBio Corp. is currently conducting a Phase I clinical trial of a nanoemulsion-based intranasal vaccine for influenza.





[edit on 4-12-2009 by neverknwo]
Pages:     ^^TOP^^



Vancouver Researcher Finds Flu Shot is Linked to H1N1 Illness
  Posted 1 days ago with 13 member flags
New AIDS-like disease found
  Posted 19 days ago with 7 member flags
Yosemite officials: 1,700 past visitors risk hantavirus
  Posted 14 days ago with 7 member flags
ALS,or Lou Gehrigs disease
  Posted 7 days ago with 3 member flags
scientists bringing back unknown plague
  Posted 19 days ago with 2 member flags
Thief targets Ebola patient, gets infected
  Posted 14 days ago with 0 member flags